Aspire-Lakewood Holdings, Inc.

ASBPW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Sep 2025
Revenue $63.1K $28.4K $1.9K
Cost of Revenue $50.8K $22.6K $1.1K
Gross Profit $-30.1K $5.8K $884
Gross Margin -47.7% 20.3% 45.5%
Operating Expenses
Research & Development $233.5K $296.7K $207.9K
SG&A Expense $970.2K $1.0M $513.0K
Operating Income $-2.7M $-1.6M $-1.1M
Operating Margin -4,244.1% -5,806.0% -59,015.8%
Interest Expense — — —
Pretax Income $-1.3M $-3.2M —
Income Tax Expense — — —
Net Income $-1.3M $-3.2M $-1.9M
Net Margin -2,009.6% -11,367.0% -95,337.1%
EPS (Basic) $-1.22 $-20.57 $-0.02
EPS (Diluted) $-1.22 $-20.57 $-0.02
Shares Outstanding (Basic) 1.0M 156.7K 99.1M
Shares Outstanding (Diluted) 1.0M 156.7K 99.1M
Dividends Per Share — — —